Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Forus
AddedMay 16, 2026
UpdatedJun 26, 2026
Forus

Forus

Series B

Forus is an AI-powered healthcare platform that automates prior authorizations and medication access support, connecting providers, pharmacies, payers, and biopharma.

HQ
New York City, NY, US
Founded
2023
Overview
Analysis
Compare
Fundraising
Employees
News
Website

Forus (formerly Tandem) is building a first-of-its-kind network that connects doctors, pharmacies, payers, and biopharma to bring new science to patients. The company's AI platform automates every step between prescription and fulfillment, replacing manual workflows with an end-to-end solution built for modern medicine.

Providers can send prescriptions to Forus and the platform automatically finds the best path to approval, saving hours of administrative work each week. Patients can finally access medications quickly and affordably, with full visibility throughout the entire process. The platform is free for both doctors and patients, HIPAA-compliant, and SOC 2 Type 2 certified. Forus is used by providers across all 50 states and supports millions of patients each year.

Forus - Products & Services

  • Medication Access Platform logo

    Medication Access Platform

    Medication Access Platform is the primary commercial offering marketed by Forus to its core customer segments.

    Competing Products

    ClaimGlide logo
    Anterior logo

Forus - Similar Companies

ClaimGlide logo

ClaimGlide

claimglide.com

Anterior logo

Anterior

anterior.com

TriFetch logo

TriFetch

trifetch.ai

Banjo Health logo

Banjo Health

banjohealth.com

Fig Medical logo

Fig Medical

figmedical.co

Latent logo

Latent

latenthealth.com

Verbal logo

Verbal

tryverbal.com

Pelica Health logo

Pelica Health

pelica.com

GProv logo

GProv

gprov.com

Shasta Health logo

Shasta Health

shasta.health

Frontier Health logo

Frontier Health

frontierhealth.ai

Co:Helm logo

Co:Helm

co-helm.com

Lamar Health logo

Lamar Health

lamarhealth.com

Ascertain logo

Ascertain

ascertain.com

Cohere Health logo

Cohere Health

coherehealth.com

Forus - Quick Facts

Who are Forus' competitors?

Companies similar to Forus include ClaimGlide, Anterior, TriFetch and Banjo Health.

When was Forus founded?

Forus was founded in 2023.

Where is Forus' headquarters located?

Forus' headquarters is located in New York City, NY, US.

When was Forus' last funding round?

Forus' most recent funding round was for $160M (USD) in May 2026.

How much has Forus raised to-date?

As of May 12, 2026, Forus has raised a total of $160M (USD).

How many employees does Forus have?

Forus has 195 employees as of May 12, 2026.

Forus - Classification

Industry
  • Health Care
Ownership
  • Privately Held
Technology
  • Artificial Intelligence
  • Machine Learning
Geographic Exposure
  • Americas
  • Americas United States
Model
  • AI Platform
  • Enterprise Software
Revenue
  • B2B
Customer
  • Healthcare Providers
  • Patients
Tags
  • Artificial Intelligence
  • Healthcare
  • SaaS